Search Results - "Unanua, N. Castro"

1479P Association between high baseline low density neutrophils and resistance to immunotherapy in untreated non-small cell lung cancer: Molecular characterization of low-density neutrophils by Arasanz, H., Castro Unanua, N., Teijeira Sanchez, L., Morilla Ruiz, I., Martínez Aguillo, M., Labiano, I., Huerta-Hernández, A.E., Piedra Roset, P., Alsina Maqueda, M., Vera, R.

Get full text

Lipid lowering treatment of severe hypertriglyceridemia with acute pancreatitis caused by everolimus in a patient with a neuroendocrine tumor by De Carlos Artajo, J, Castro Unanua, N, Muruzábal Huarte, E, Vera García, R, Irigaray Echarri, A, Zubiría Gortázar, J, Anda Apiñániz, E

“…Everolimus is an mTOR inhibitor, approved as a treatment for cancer and as an immunosuppressant agent in solid organ transplantation; it frequently produces…”
Get full text

1408P Differences on immune biomarkers between KRAS G12C and KRAS non-G12C mutated non-small cell lung cancer by Masfarre Pinto, L., Parreira, A.S.D.F.M., Castro Unanua, N., Rocha, P., Morilla Ruiz, I., Teijeira Sanchez, L., Clave, S., Navarro Gorro, N., Bach Mora, R., Sánchez, I., Galindo Campos, M.A., Taus Garcia, A., Azkárate Martínez, A., Marse Fabregat, R., Bellosillo Paricio, B., Arasanz, H., Martínez Aguillo, M., Arriola, E.

Get full text

1394P Frequentist and Bayesian analysis of second line treatment effectiveness in AGAMENON-SEOM gastric cancer registry by Martinez Lago, N., Carmona-Bayonas, A., Pieras Lopez, A., Ramchandani, A., Longo, F., Martin Carnicero, A., Granja Ortega, M., Calvo, A., Hernandez, R., Castro Unanua, N., Assaf, J.D., Azkarate, A., Hernandez-Perez, C., Camara, J.C., Saurí, T., Custodio, A., Cano, J.M., Fernandez Montes, A., Martinez de Castro, E., Gallego, J.

Get full text

1410P Gastric cancer: Data from the AGAMENON-SEOM study by Macias Declara, I., Mihic, L., Calvo, A., Hernandez, R., Castro Unanua, N., Cacho, D., Custodio, A., Cano, J.M., Fernandez Montes, A., Diez, M., López, F., Visa Turmo, L., Vidal Tocino, R., Limon, M.L., Pimentel, P., Mangas Izquierdo, M., Paez, D., Asensio-Martinez, E., Carmona-Bayonas, A., Jimenez-Fonseca, P.

Get full text

Tratamiento hipolipemiante de la pancreatitis aguda secundaria a hipertrigliceridemia severa por everolimus en un paciente con tumor neuroendocrino by Artajo, J. de Carlos, Castro Unanua, N., Muruzábal Huarte, E., Vera García, R., Irigaray Echarri, A., Zubiría Gortázar, J., Anda Apiñániz, E.

“…Resumen Everolimus es un inhibidor de mTOR, empleado en oncología y como inmunosupresor en el trasplante de órgano sólido. Sus efectos adversos a nivel…”
Get full text

55P Differences in response to immune treatment between KRAS G12C and KRAS non-G12C mutated non-small cell lung cancer by Pinto, L. Masfarre, De Freitas Matos-Parreira, A.S., Unanua, N. Castro, Da Rocha, P.F. Simoes, Ruiz, I. Morilla, Sanchez, L. Teijeira, Clave, S., Gorro, N. Navarro, Mora, R. Bach, Sánchez, I., Galindo Campos, M.A., Garcia, A. Taus, Martínez, A. Azkárate, Fabregat, R. Marse, Paricio, B. Bellosillo, Arasanz, H., Aguillo, M. Martínez, Gómez, C., Company, A., Arriola, E.

Get full text